Patents by Inventor Ümit Kayisli

Ümit Kayisli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTION OF PRETERM BIRTH (PTB) BY INHIBITION OF FKBP51
    Publication number: 20220096494
    Abstract: The disclosure is directed to a method of enhancing progesterone receptor (PR) activity in a mammal, which comprises administering a composition comprising an inhibitor of FK506 binding protein 51 (FKBP51) to a mammal in need thereof, such as a pregnant human female, whereby progesterone receptor activity in the mammal is enhanced as compared to a mammal not administered the composition. The method results in an extension of the gestation period and a decreased likelihood of preterm birth and fetal growth restriction.
    Type: Application
    Filed: December 13, 2021
    Publication date: March 31, 2022
    Inventors: Charles Lockwood, Özlem Guzeloglu-Kayisli, Ümit Kayisli, Frederick Schatz
  • Prevention of preterm birth (PTB) by inhibition of FKBP51
    Patent number: 11197868
    Abstract: The disclosure is directed to a method of enhancing progesterone receptor (PR) activity in a mammal, which comprises administering a composition comprising an inhibitor of FK506 binding protein 51 (FKBP51) to a mammal in need thereof, such as a pregnant human female, whereby progesterone receptor activity in the mammal is enhanced as compared to a mammal not administered the composition. The method results in an extension of the gestation period and a decreased likelihood of preterm birth and fetal growth restriction.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: December 14, 2021
    Assignee: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Charles Lockwood, Özlem Guzeloglu-Kayisli, Ümit Kayisli, Frederick Schatz
  • PREVENTION OF PRETERM BIRTH (PTB) BY INHIBITION OF FKBP51
    Publication number: 20190388433
    Abstract: The disclosure is directed to a method of enhancing progesterone receptor (PR) activity in a mammal, which comprises administering a composition comprising an inhibitor of FK506 binding protein 51 (FKBP51) to a mammal in need thereof, such as a pregnant human female, whereby progesterone receptor activity in the mammal is enhanced as compared to a mammal not administered the composition. The method results in an extension of the gestation period and a decreased likelihood of preterm birth and fetal growth restriction.
    Type: Application
    Filed: February 23, 2018
    Publication date: December 26, 2019
    Inventors: Charles Lockwood, Özlem Guzeloglu-Kayisli, Ümit Kayisli, Frederick Schatz